Pfizer Names New Chief Scientific Officer and President of R&D

Contract Pharma·Nov 20

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Pfizer has named a new chief scientific officer and president of research and development. The new R&D chief is reportedly the company's head of oncology, with some outlets identifying the individual as Chris Boshoff. The previous R&D chief's status is unclear, with one report indicating a former Pfizer R&D chief has taken a position at another company.

Full coverage

Pfizer Names Dr. Chris Boshoff Chief Scientific Officer

Pfizer·May 6

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board

Yahoo Finance Singapore·Jul 9

Pfizer, under pressure to change, names oncology head as new R&D chief

BioPharma Dive·Nov 20

Ousted FDA official joins Lilly; Novo names global research head as layoffs come into focus

Endpoints News·Sep 12

Pfizer names oncology head Chris Boshoff as R&D chief

Reuters·Nov 20

Doubling down on its strategy, Pfizer names its head of oncology as new research chief

STAT·Nov 20

Pfizer Names New R&D Chief

WSJ·Nov 20

Pfizer Names Chris Boshoff as New Chief Scientific Officer, R&D Chief

Medical Dialogues·Nov 22

View original report at Contract Pharma ↗

Fetching the latest headlines…